Metformin protects against intestinal barrier dysfunction via AMPKα1‐dependent inhibition of JNK signalling activation

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|22|1|546-557

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.22, Iss.1, 2018-01, pp. : 546-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wild‐type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1792-1804

John Wiley & Sons Inc

Access to resources Recommend Favorite

CDK7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF‐κB activation and IL‐1β/IL‐6 secretion

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 2, 2018-02 ,pp. : 1292-1301

John Wiley & Sons Inc

Access to resources Recommend Favorite

The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 1, 2018-01 ,pp. : 600-612

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rosiglitazone via PPARγ‐dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 4, 2015-04 ,pp. : 826-835

John Wiley & Sons Inc

Access to resources Recommend Favorite

High glucose‐induced intestinal epithelial barrier damage is aggravated by syndecan‐1 destruction and heparanase overexpression

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 6, 2015-06 ,pp. : 1366-1374

John Wiley & Sons Inc

Access to resources Recommend Favorite